Amyris Buys Ingredion’s Stake in the Real Sweet Joint Venture

Amyris and Ingredion Incorporated (NYSE:INGR) have agreed to end their RealSweet joint venture.

Amyris buys Ingredion's stake in the Real Sweet Joint Venture

A close up of a baker stirring a bowl of flour and sugar in a bakery.

Amyris will take complete control of the Precision Fermentation Plant in Barra Bonita, Brazil, as part of the new agreement. As a result, Ingredion Incorporated is granted exclusive access to Amyris’ fermented Reb M technology for production and marketing, setting the stage for future collaboration. Both businesses will benefit from improved operational focus and commercial clarity as an outcome of the strategic pivot.

Amyris, a synthetic biology pioneer, will fully oversee its Brazilian laboratory, strengthening its vertically integrated approach. Sustainable components used in products all around the world are produced by the company’s in-house fermentation platform.

Ingredion Incorporated, a worldwide ingredient producer with $7.4 billion in sales in 2024 and operations in more than 120 countries, will use its exclusive rights to fermented Reb M, a sugar substitute.

Through this collaboration, Amyris fortifies its core production capabilities for future expansion, while Ingredion expands its portfolio of functional sweeteners.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.